Welcome to the Newsroom

From the latest health and nutrition solutions to making an impact on people and the planet, check out our top stories. To contact our U.S. media relations team, please email nhscusmedia@us.nestle.com

Tufts Press Release_Kresko_v1_Newsroom

Nestlé Health Science and the Food & Nutrition Innovation Institute at the Friedman School at Tufts University Announce Winner of 2nd Annual Innovation Challenge

Learn More
Natures Bounty Logo

Nature’s Bounty® Introduces New Plant-Based Omega-3 Supplement

Learn More
logonhsf

Nestlé Health Science Foundation Raises $660K During Annual Golf Outing to Strengthen Communities

Learn More
Orgain

Alex Morgan Teams Up with Orgain to Help Fuel Her Journey to Compete in The World’s Largest Women’s Soccer Event

June 06, 2023

Read More
Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST

Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST™, the First and Only FDA-Approved Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection

June 05, 2023

Read More
Nature's Bounty

NATURE’S BOUNTY® UNVEILS NEW OPTIONS FOR WOMEN SEARCHING FOR HAIR LOSS AND WEIGHT MANAGEMENT PRODUCTS WITH CLINICALLY RESEARCHED INGREDIENTS

May 16, 2023

Read More
Vowst Announcement Press Release

Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST™ a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

May 08, 2023

Read More
Vowst AnnouncementPress Release

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI

April 26, 2023

Read More
Orgain Earns B Corp™ Certification

Orgain Earns B Corp™ Certification

March 16, 2023

Read More